xtalpi

Keep you updated

with the latest info of XtalPi

Hit Identification – SARM1 Structural Elucidation By Internal Cryo-EM Platform
Identifying Novel FGFR3 Inhibitors By XtalPi-Curated HTS Diversity Library
How XtalPi Utilized MicroED to Tackle Different Polymorphism Challenges
Accelerated Identification of the Most Stable Remdesivir Polymorph in 33 Days Using an Integrated Experimental and Computational Approach
Hit Identification – Novel Hits for GPX4
About XtalPi, a pioneering AI drug discovery company
MIT and XtalPi Forge Partnership to Pioneer AI-Driven Scientific Discovery
Intelligent Cloud-Based Algorithms for Pharmaceutical Drug Formulation and Development
Application Note: DEL Screening
Dr. Wen Shuhao Appointed to MIT Visiting Committee, Becoming Youngest Member in Chemistry Division
Novel Computational Approach to Guide Impurities Rejection by Crystallization: A Case Study of MRTX849 Impurities
Structural identification of vasodilator binding sites on the SUR2 subunit
Toward accurate and efficient dynamic computational strategy for heterogeneous catalysis: Temperature-dependent thermodynamics and kinetics for the chemisorbed on-surface CO

Search XtalPi

Unlock Faster, Smarter Polymorph Screening with XtalGazer™ CSP
Unlock Faster, More Accurate Drug Discovery with XFEP
Templated Nucleation of Clotrimazole and Ketoprofen on Polymer Substrates

XtalPi Newsletter